Companies Dominating the Drug Delivery System Landscape
- BD (Becton, Dickinson, and Company)
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Gerreshelmer AG
- Baxter
- Nemara
- Kindeva Drug Delivery
- West Pharmaceutical Services Inc.
- Ypsomed
- Medtronic Inc.
- E3D Elcam Drug Delivery Devices
- Astra Zeneca
- Merck KGaA
Browse Key Market Insights with Data Illustration:
In the News
- Nemara announced the sponsorship of Celie Gross for their latest launch Wearable Injectors of On Drug Delivery. The product is designed to suffice the unmet drug delivery needs in chronic diseases. The lack of simultaneous response to the challenges related to biologics, self-administration, connectivity, and sustainability in one device is a driving force behind the thought that it would be good for patients who suffer from chronic disease to have an intelligent, sustainable on-body injector.
- Merck KGaA announces a collaboration with InnoCore Pharmaceuticals to provide Innocare with the proprietary SynBiosys biodegradable polymer platform. It is a drug delivery platform developed to reduce the hurdles in injectable formulation. This collaboration will enable new and potentially life-changing drugs to be made available, by creating a prolonged release of protein therapeutic products into the market. By reducing dosing frequency and maintaining medicines at therapeutic levels for longer, it will also improve patient compliance.
